Regression of skin lesions of Kyrle's disease with metronidazole in a diabetic patient

J Infect. 2007 Dec;55(6):e139-40. doi: 10.1016/j.jinf.2007.07.023. Epub 2007 Oct 1.

Abstract

We describe here in a case of a 41-year-old man, with diabetes mellitus, who presented manifestations of Kyrle's disease. Administration of metronidazole, 500 mg twice daily for 1 month, resulted in complete regression of skin lesions with no recurrence during 12 months of follow-up. This successful antibiotic treatment is to support the role of infectious agents (anaerobic bacteria) in the pathogenesis of Kyrle's disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Infective Agents / therapeutic use*
  • Diabetes Mellitus / pathology
  • Humans
  • Keratosis / drug therapy*
  • Keratosis / etiology
  • Male
  • Metronidazole / administration & dosage*
  • Metronidazole / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Metronidazole